Comparison of FOLFOX and FOLFIRI adjuvant chemotherapy regimens in the treatment of colorectal mucinous adenocarcinoma

doi:10.3877/cma.j.issn.2095-3224.2016.02.09

Abstract

Abstract:

Objective

To evaluate the clinical effect of FOLFOX regimen and FOLFIRI regimen in the treatment of colorectal mucinous adenocarcinoma after operation.

Methods

40 patients confirmed mucinous adenocarcinoma by surgery and pathology were divided randomly into two groups. Twenty patients (Group FOLFOX) were treated with oxaliplatin combined with 5-fluorouracil, while the other Twenty patients (Group FOLFIRI) were treated with irinotecan combined with 5-fluorouracil. The progression free survival (PFS) of two groups was compared. Survival was estimated using the Kaplan-Meier method.

Results

The PFS of Group FOLFOX is 13 months, while the PFS of Group FOLFIRI is 18 months. Differences are statistically significant (χ²=4.294, P=0.038).

Conclusion

Colorectal mucinous adenocarcinoma after operation treated with FOLFIRI regimen can prolong PFS than FOLFOX regimen.

Key words: Colorectal neoplasms, Therapy, Mucinous adenocarcinoma, Adjuvant chemotherapy

Shan Liu, Lingxin Meng, Ke Zhang, Zhaoyang Qin, Gangping Wang, Qin Meng, Zhaojun Ding. Comparison of FOLFOX and FOLFIRI adjuvant chemotherapy regimens in the treatment of colorectal mucinous adenocarcinoma[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2016, 05(02): 159-162.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjzcjbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3224.2016.02.09

https://zhjzcjbdzzz.cma-cmc.com.cn/EN/Y2016/V05/I02/159

Figures/Tables 3

References 14

[1]	Hyngstrom JR, Hu CY, Xing Y, et al. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base.Ann Surg Oncol, 2012, 19(9): 2814-2821.
[2]	Hugen N, Verhoeven RH, Radema SA, et al. Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma.Ann Oncol, 2013, 24(11): 2819-2824.
[3]	Consorti F, Lorenzotti A, Midiri G, et al. Prognostic significance of mucinous carcinoma of colon and rectum: a prospective case-control study. J Surg Oncol, 2000, 73(2): 70-74.
[4]	Hyngstrom JR, Hu CY, Xing Y, et al. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol, 2012, 19(9): 2814-2821.
[5]	Jivapaisarnpong P, Boonthongtho K.Clinicopathological characteristics of mucinous and non-mucinous adenocarcinoma in the colonand rectum in Rajavithi Hospital, Thailand.J Med Assoc Thai, 2011, 94(Suppl 2): S41-45.
[6]	Barresi V, Reggiani Bonetti L, Ieni A, et al. Prognostic significance of grading based on the counting of poorly differentiated clusters in colorectalmucinous adenocarcinoma. Hum Pathol, 2015, 46(11): 1722-1729.
[7]	Zamir N, Ahmed S, Akhtar J. Mucinous adenocarcinoma of colon.APSP J Case Rep, 2010, 1(2): 20.
[8]	Catalano V, Loupakis F, Graziano F, et al. Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer. Ann Oncol, 2012, 23(1): 135-141.
[9]	Kim SH, Shin SJ, Lee KY, et al. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III coloncancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study. Ann Surg Oncol, 2013, 20(11): 3407-3413.
[10]	Negri FV, Wotherspoon A, Cunningham D, et al Norman AR. Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer. Ann Oncol, 2005, 16(8): 1305-1310.
[11]	Javier Martinez-Useros, Maria Rodriguez-Remirez, Aurea Borrero-Palacios, et al. DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer. BMC Cancer, 2014, 14: 965.
[12]	Oberholzer K, Menig M, Kreft A, et al. Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation. Int J Radiat Oncol Biol Phys, 2012, 82(2): 842-848.
[13]	Cao Y, Jin ZX, Tong XP, et al. Synergistic effects of topoisomerase Iinhibitor, SN38, on Fas-mediated apoptosis. Anticancer Res, 2010, 30(10): 3911-3917.
[14]	Nöpel-Dünnebacke S, Schulmann K, Reinacher-Schick A, et al. Prognostic value of microsatellite instability and p53 expression in metastatic colorectal cancer treated with oxaliplatin and fluoropyrimidine-based chemotherapy. Z Gastroenterol, 2014, 52(12): 1394-1401.

组别	性别		肠癌部位		术后病理分期
组别	男	女	直肠癌	结肠癌	II期	III期
FOLFOX组	14	6	16	4	4	16
FOLFIRI组	15	5	14	6	3	17
χ²	0.003		0.006		0.040
P值	0.72		1.00		0.68

组别	性别		肠癌部位		术后病理分期
组别	男	女	直肠癌	结肠癌	II期	III期
FOLFOX组	14	6	16	4	4	16
FOLFIRI组	15	5	14	6	3	17
χ²	0.003		0.006		0.040
P值	0.72		1.00		0.68

[1]	Wei Zhang. Dentoalveolar surgery: The pioneer of comfortable treatment [J]. Chinese Journal of Stomatological Research(Electronic Edition), 2023, 17(06): 386-388.
[2]	Dechen Wang, Kang Yang, Zijie Yang, Mingbin Gui, Lianping Qu, Xiaofeng Zhang, Feng Gao. Progress of microsatellite stability state and PD-1/PD-L1/IDO in colorectal carcinoma [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 462-465.
[3]	Xu Tang, Bing Han, Wei Liu, Ruxing Chen. Analysis of risk factors for metachronous liver metastases after radical colorectal cancer surgery and construction of a predictive model [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 16-20.
[4]	Shengjun Zhang, Ajing Zhao, Shoubo Li, Xianghong Hao, Minli Liu. An experimental study on the promotion of colorectal cancer invasion and migration by high glucose through HGF/c-met pathway [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 21-24.
[5]	Yanhui Zhang, Jiao Zhang, Zhixian Zhu. Effect of indwelling anal tube on anastomotic leakage after laparoscopic total mesangectomy after neoadjuvant chemoradiotherapy in patients with middle and low rectal cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 25-28.
[6]	Zhibo Gu, lin Hao, Ming Lu, Jiangang Chen. Photodynamic nanocarriers combined with siP3H4 for precise targeting therapy in the treatment of bladder cancer: a pilot study [J]. Chinese Journal of Endourology(Electronic Edition), 2023, 17(06): 633-641.
[7]	Bo Kong, Jing Zhang, Ke Lyu. Review on the role of ultrasonography in the diagnosis and treatment of complex ventral hernia [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2023, 17(06): 670-673.
[8]	Xilin Du, Kai Tan, Xiaojun He. Conversion therapies for hepatocellular carcinoma [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(06): 597-601.
[9]	Xiaoyong Wei. Discussion on the focus issues of conversion therapy for primary liver cancer [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(06): 602-607.
[10]	Chenrui Wu, Rui Liao, Qiang He. Hepatic arterial infusion chemotherapy combined immunotargeted therapy for multiple metastatic hepatocellular carcinoma in a multi-disciplinary treatment model: a case report [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(06): 713-716.
[11]	Guangjun Zhong, Chunhua Liu, Wansen Zhu, Xiaolei Xu, Zhaojun Wang. Application of conventional MRI combined with different scanning sequences in preoperative staging diagnosis, chemotherapy efficacy and prognosis evaluation of gastric cancer [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 378-382.
[12]	Qiujie Shan, Lizhu Sun, Yiquan Xu, Zhixia Wang, Yan Xu, Hao Ma, Tiantian Liu. Construction and application of radiation-induced lung injury risk model for middle-aged and elderly patients with esophageal cancer during intensity modulated radiotherapy [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 388-393.
[13]	Baoru Hu, Naijian Shang, Di Gao. DCE-MRI and DWI findings of advanced hepatocellular carcinoma and their correlation with prognosis after immunotherapy [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 399-403.
[14]	Xiankui Gao, Taiyun Zhao, Xingjun Lu, Hongling Zhang, Xiuluo Fang, Bichun Yan, Yin Wang, Yongcui Wang, Miaomiao Liu, Ruonan Ran. Efficacy of endoscopic electrocoagulation and tissue glue injection in the treatment of upper gastrointestinal ulcer with bleeding [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 452-455.
[15]	Ruixue Yue, Lingxin Kong, Xin Hao, Jinqiang Yang, Meng Han, Guozhong Cui, Jianjun Wang, Zhisheng Zhang, Fanting Kong, Wei Zhang, Wenbo He, Xianqiao Li, Xinping Zhou, Donghong Xu, Chongzhu Hu. HER2 protein expression levels predict efficacy of neoadjuvant therapy in breast cancer: A real-world study [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(07): 765-770.

Please choose a citation manager

Content to export